ENTRY       D11800                      Drug
NAME        Vixarelimab (USAN)
FORMULA     C6416H9906N1700O2037S48
EXACT_MASS  144897.0411
MOL_WEIGHT  144986.5926
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYEINWVRQA TGQGLEWMGW MNPNSGYTGY
            AQKFQGRVTM TRDTSISTAY MEMSSLRSED TAVYYCARDI VAANTDYYFY YGMDVWGQGT
            TVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
            AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE
            QFQSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS
            RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PG
            (Light chain)
            QSVLTQPPSA SGTPGQRVTI SCSGSNSNIG SNTVNWYHQL PGTAPKLLIY NINKRPSGVP
            DRFSGSKSGS SASLAISGLQ SEDEADYYCS TWDDSLDGVV FGGGTKLTVL GQPKAAPSVT
            LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADSSPVK AGVETTTPSK QSNNKYAASS
            YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
            (Disulfide bridge: H22-H96, H140-L215, H153-H209, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'140-L'215, H'153-H'209, H'267-H'327, H373-H'431, L22-L89, L138-L197, L'22-L'89, L'138-L'197)
  TYPE      Peptide
EFFICACY    Antipruritic, Anti-oncostatin M receptor antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of chronic pruritic diseases
TARGET      OSMR [HSA:9180] [KO:K05057]
  PATHWAY   hsa04060(9180)  Cytokine-cytokine receptor interaction
            hsa04151(9180)  PI3K-Akt signaling pathway
            hsa04630(9180)  JAK-STAT signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                OSMR
                 D11800  Vixarelimab (USAN)
DBLINKS     CAS: 2243320-83-2
            PubChem: 405226666
///
